<DOC>
	<DOCNO>NCT01846702</DOCNO>
	<brief_summary>The main purpose study evaluate safety tolerability study drug know LY3084077 healthy participant . The study also investigate much study drug get blood stream long take body get rid . Information side effect may occur also collect . The study expect last approximately 8 week participant .</brief_summary>
	<brief_title>A Study LY3084077 Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Have normal blood pressure Must healthy male female become pregnant Have body mass index ( BMI ) 18.5 40.0 kg/m^2 , inclusive , screen Have know allergy fibroblast growth factor21 ( FGF21 ) analogue , glucagonlike peptide1 ( GLP1 ) , GLP1analogues relate compound Have previous exposure FGF21 analogues GLP1 analogue Have receive live vaccine ( ) within 1 month screening , intend study Have previously complete withdrawn study Have use health problem laboratory test result electrocardiogram ( ECG ) read opinion doctor , could make unsafe participate , interfere understand result study Have receive treatment biologic agent ( monoclonal antibody ) within 3 month 5 halflives ( whichever longer ) prior dose Have problem immune system , due disease treatment Have personal family history medullary thyroid carcinoma ( MTC ) multiple endocrine neoplasia syndrome type 2 Have history pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>